Analysis
Oura filed a public S-1 registration statement with the SEC on Wednesday, confirming plans to list on Nasdaq under ticker OURA and targeting a raise of up to $3 billion at a valuation above $16 billion, according to Bloomberg and Tech Times. The filing follows Oura's confidential submission in May and a TechCrunch report in August that first floated the September timeline. Pulse has tracked Oura's IPO buildup since the confidential filing.
The numbers are the story: revenue reached $1.21 billion for the nine months ended June 30, up 74% from $697.6 million a year earlier, with a 55% gross margin, $60.8 million in net income, and $106.7 million in adjusted EBITDA over that period.
Paid members reached 5.0 million, up from 2.5 million a year earlier, and Oura sold 3.6 million rings over the trailing twelve months -- roughly 2% of global wearable shipments per IDC. Goldman Sachs, Morgan Stanley, JPMorgan, Allen & Company, and Jefferies lead the offering, with BofA Securities, Barclays, and Robinhood Securities among a dozen additional underwriters.
A rare profitable consumer-hardware IPO
Profitability at this growth rate is unusual for a consumer wearables company going public -- Fitbit never reached durable profitability before its 2021 Google acquisition, and most direct-to-consumer hardware IPOs of the past decade have leaned on growth-at-all-costs narratives rather than net income. Oura's closer public comparable is arguably Garmin, which is profitable but growing far more slowly, or Whoop, which remains private and subscription-only without hardware margin. The company's competitive position rests on its smart-ring form factor against Apple Watch, Samsung Galaxy Ring, and Fitbit's broader wearables push, none of which combine Oura's specific health-sensing focus with its subscription-membership model.
Tech Times separately reported that early investors have already cashed out roughly $1 billion in secondary sales ahead of this filing -- worth reading carefully in the prospectus's use-of-proceeds and insider-lockup sections, since heavy pre-IPO secondary selling can signal insiders extracting value before public-market risk transfers to new shareholders. Oura also arrives in a September IPO window crowded with AI infrastructure names -- Crusoe reportedly meeting bankers off a fresh $30 billion private valuation -- competing for the same limited pool of institutional IPO allocation dollars this month.
